Steep Hill Inc.

STPH

CA85832P2089

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 03:51:14 2024-04-12 pm EDT			5-day change	1st Jan Change
0.025 ^CAD	0.00%		0.00%	-28.57%

Apr. 16	Steep Hill Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Steep Hill Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Steep Hill Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022

May 30, 2022 at 05:41 pm EDT

Steep Hill Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CAD 0.903455 million. Net loss was CAD 0.887501 million compared to CAD 0.967211 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.

Latest news about Steep Hill Inc.

Steep Hill Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
Steep Hill Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 28	CI
Steep Hill Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-28	CI
Steep Hill Inc. Announces Demise of Director, David Walters	23-07-04	CI
Steep Hill Inc. Announces Chief Financial Officer Change	23-06-03	CI
Steep Hill Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-30	CI
Steep Hill Inc. Auditor Raises 'Going Concern' Doubt	23-04-30	CI
Steep Hill Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-30	CI
Steep Hill Inc. Enters into a Settlement and Release Agreement	23-03-01	CI
Steep Hill Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-29	CI
Steep Hill Inc. to Close Canadian Lab and Focus on US Operations	22-09-02	CI
Steep Hill Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-19	CI
Steep Hill Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-30	CI
Steep Hill Michigan Achieves ISO 17025:2017 Accreditation	22-05-18	CI
Steep Hill Inc. Enters into A Licensing Agreement with SH Lab Holdings LLC, Expanding Its Network of Licensees to the State of Vermont	22-05-06	CI
Steep Hill Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-02	CI
Steep Hill Inc. Auditor Raises 'Going Concern' Doubt	22-05-01	CI
Steep Hill Inc. will Change its Ticker to STPH from CBDX	22-02-28	CI
Canbud Distribution Corp. will Change its Name to Steep Hill Inc	22-02-28	CI
Canbud Distribution Corporation will Change its Ticker to STPH from CBDX	22-02-28	CI
Canbud Distribution Corporation will Change its Name to Steep Hill Inc	22-02-28	CI
Canbud CEO Departs, Replacement Named	22-02-01	MT
Canbud Distribution Corporation Announces Executive Changes	22-02-01	CI
Canbud Distribution Corporation Announces Directorate Changes	22-02-01	CI
Canbud Distribution Corporation completed the acquisition of Steep Hill, Inc.	22-01-30	CI

Chart Steep Hill Inc.

Duration

Period

More charts

Company Profile

Steep Hill Inc. is a Canada-based company. The Company is engaged in the process of restructuring its business and is exploring strategic alternatives.

Sector

Pharmaceuticals

Calendar

2024-05-27 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
STEEP HILL INC.	-28.57%	295K
DONG-E-E-JIAO CO.,LTD.	+35.04%	5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.14%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.53B